Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore Points
- 2 March 2004
- journal article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Computer Sciences
- Vol. 44 (3) , 1111-1122
- https://doi.org/10.1021/ci034270n
Abstract
Pharmacophore modeling can provide valuable insight into ligand-receptor interactions. It can also be used in 3D (dimensional) database searching for potentially finding biologically active compounds and providing new research ideas and directions for drug-discovery projects. To stimulate the structure-based drug design against SARS (severe acute respiratory syndrome), a pharmacophore search was conducted over 3.6 millions of compounds based on the atomic coordinates of the complex obtained by docking KZ7088 (a derivative of AG7088) to SARS CoV M(pro) (coronavirus main proteinase), as reportedly recently (Chou, K. C.; Wei, D. Q.; Zhong, W. Z. Biochem. Biophys. Res. Commun. 2003, 308, 148-151). It has been found that, of the 3.6 millions of compounds screened, 0.07% are with the score satisfying five of the six pharmacophore points. Moreover, each of the hit compounds has been evaluated for druggability according to 13 metrics based on physical, chemical, and structural properties. Of the 0.07% compounds thus retrieved, 17% have a perfect score of 1.0; while 23% with one druggable rule violation, 13% two violations, and 47% more than two violations. If the criterion for druggability is set at a maximum allowance of two rule violations, we obtain that only about 0.03% of the compounds screened are worthy of further tests by experiments. These findings will significantly narrow down the search scope for potential compounds, saving substantial time and money. Finally, the featured templates derived from the current study will also be very useful for guiding the design and synthesis of effective drugs for SARS therapy.Keywords
This publication has 19 references indexed in Scilit:
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003
- The Use of Corticosteroids in SARSNew England Journal of Medicine, 2003
- Nonleadlikeness and leadlikeness in biochemical screeningDrug Discovery Today, 2003
- Virtual screening using grid computing: the screensaver projectNature Reviews Drug Discovery, 2002
- Drug-like Index: A New Approach To Measure Drug-like Compounds and Their DiversityJournal of Chemical Information and Computer Sciences, 2000
- Drug-like properties and the causes of poor solubility and poor permeabilityJournal of Pharmacological and Toxicological Methods, 2000
- Property distribution of drug-related chemical databases*Journal of Computer-Aided Molecular Design, 2000
- A Scoring Scheme for Discriminating between Drugs and NondrugsJournal of Medicinal Chemistry, 1998
- Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?Journal of Medicinal Chemistry, 1998
- Reactive compounds and in vitro false positives in HTSDrug Discovery Today, 1997